Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for hidden genes behind common bleeding disorder

NCT ID NCT05116501

First seen Jun 08, 2026 · Last updated Jun 22, 2026 · Updated 4 times

Summary

This study looked at the DNA of 254 people to find genetic reasons for low von Willebrand factor, a mild bleeding condition. Researchers used whole-exome sequencing to check for changes in known and new genes. The goal was to better understand why some people have low levels of this clotting protein.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW VON WILLEBRAND FACTOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, A.B.Bonomi Hemophilia and Thrombosis Center

    Milan, Lombardy, 20122, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could identify new genes that cause low von Willebrand factor, leading to better diagnosis and understanding of the condition.

What could go wrong

This is an observational study, not a treatment trial. It may not find clear genetic causes, and results may not change patient care directly.

Conditions

The condition(s) this trial relates to.

von Willebrand disease (hereditary or acquired) von Willebrand disease 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.